NCT02538549

Brief Summary

Behavioral activation (BA) is a low cost, evidence-based intervention that can be effective in treating depression and anxiety. We have developed a behavioural activation card game for clients receiving treatment through the Crisis Team and Traditional Case Management (TCM) in Kingston, ON. The game is designed to integrate behavioural activation tools into daily life while receiving points for completion of the each Activity Challenge, which are divided into 4 areas (ACE4), with the goal to receive maximum amount of points in the timeframe of the study. Using a Randomized Control Trial (RCT) design, participants (n=40) will be assigned to one of two groups, with the intervention group receiving ACE4 and treatment as usual (TAU) and the control group only receiving TAU. Assessments will be carried out upon entry to the study and at the end of the intervention period (8 weeks). Assessments will be completed using the WHODAS 2.0 (World Health Organization Disability Assessment Schedule), HADS (The Hospital Anxiety and Depression Scale), and CORE (Clinical Outcome in Routine Evaluation). We hypothesize that the treatment group receiving the ACE4 intervention will show improvement in overall mental state. Analyses will be conducted using SPSSv16, an analysis of covariance and t-test, and a binary logistic regression analysis will be used to investigate factors that predict good outcomes. Results will be published in international journals and presented at conferences with an aim towards being applied to clinics in Pakistan.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2015

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2015

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

August 29, 2015

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 2, 2015

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2016

Completed
Last Updated

September 2, 2015

Status Verified

August 1, 2015

Enrollment Period

1 year

First QC Date

August 29, 2015

Last Update Submit

August 29, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • The Hospital Anxiety and Depression Scale (HAD)

    A 14 item, self assessment scale designed to measure anxiety and depression. It has a high internal consistency, face validity and concurrent validity. Even-numbered questions relate to depression and odd-numbered questions relate to anxiety. Each question has 4 possible responses. Responses are scored on a scale from 3 to 0. The maximum score is therefore 21 for depression and 21 for anxiety. A score of 11 or higher indicates the probable presence of the mood disorder with a score of 8 to 10 being just suggestive of the presence of the respective state. The two subscales, anxiety and depression, have been found to be independent measures. In its current form the HADS is now divided into four ranges: normal (0-7), mild (8-10), moderate (11-15) and severe (16-21).

    At the base line and then at the end of therapy (8 weeks).

Secondary Outcomes (2)

  • The Clinical Outcome in Routine Evaluation (CORE)

    At the base line and then at the end of therapy (8 weeks).

  • Brief Disability Questionnaire (BDQ)

    At the base line and then at the end of therapy (8 weeks).

Study Arms (2)

ACE4 and TAU

ACTIVE COMPARATOR

This group will receive ACE4 as an intervention and treatment as usual.

Behavioral: ACE4

TAU Only

NO INTERVENTION

This group will receive only the treatment as usual.

Interventions

ACE4BEHAVIORAL

Activity Challenge 4 is a single player card game that is based on principles of behavioral activation. The game was used with crisis and transitional case management clients, with positive feedback.

ACE4 and TAU

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Fulfill the diagnostic criteria of Depressive episode (F32) or Recurrent depressive disorder (F33 except 33.4 ) using ICD10 RDC (based on interviews using SCAN Urdu version).
  • Between the ages of 18 to 65
  • Score 8 or more on HADS, Depression Subscale.
  • Patients will be asked to attend a further appointment at the end of study period and will be assessed again.

You may not qualify if:

  • Excessive use of alcohol or drugs (using ICD 10 RDC for alcohol or drug abuse or dependence).
  • Significant cognitive impairment (for example learning disability or dementia).
  • Active psychosis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Addiction & Mental Health Services - Kingston Frontenac Lennox & Addington

Kingston, Ontario, K7L 1B9, Canada

RECRUITING

MeSH Terms

Conditions

Anxiety DisordersLymphoma, Follicular

Condition Hierarchy (Ancestors)

Mental DisordersLymphoma, Non-HodgkinLymphomaNeoplasms by Histologic TypeNeoplasmsLymphoproliferative DisordersLymphatic DiseasesHemic and Lymphatic DiseasesImmunoproliferative DisordersImmune System Diseases

Study Officials

  • Farooq Naeem, MsC, PhD

    Queen's University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 29, 2015

First Posted

September 2, 2015

Study Start

August 1, 2015

Primary Completion

August 1, 2016

Study Completion

August 1, 2016

Last Updated

September 2, 2015

Record last verified: 2015-08

Locations